MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1041 to 1060 of 166,322 approvalsPage 53 of 8317

Pomalidomide Capsules

Approval Number: 国药准字H20253721
Registration: Mar 25, 2025

Esmolol Hydrochloride Injection

Approval Number: 国药准字H20253719
Registration: Mar 25, 2025

Iohexol Injection

Approval Number: 国药准字H20253737
Registration: Mar 25, 2025

Thioctic Acid Tablets

Approval Number: 国药准字H20253713
Registration: Mar 25, 2025

Vitamin B₁₂ Eye Drops

Approval Number: 国药准字H20253705
Registration: Mar 25, 2025

Olanzapine Tablets

Approval Number: 国药准字H20253702
Registration: Mar 25, 2025

Arbidol Hydrochloride Tablets

Approval Number: 国药准字H20253696
Registration: Mar 25, 2025

Riluzole Tablets

Approval Number: 国药准字HC20250002
Registration: Mar 25, 2025
kenton chemicals and pharmaceuticals corporation

Rivaroxaban Tablets

Approval Number: 国药准字H20258041
Registration: Mar 25, 2025

Acetylcysteine Solution for Inhalation

Approval Number: 国药准字H20253679
Registration: Mar 25, 2025

Fudosteine Oral Solution

Approval Number: 国药准字H20253709
Registration: Mar 25, 2025

Pyrantel Pamoate Tablets

Approval Number: 国药准字H41021020
Registration: Mar 24, 2025

Phenprobamate Tablets

Approval Number: 国药准字H41020717
Registration: Mar 24, 2025

Valacyclovir Hydrochloride Tablets

Approval Number: 国药准字H20258039
Registration: Mar 24, 2025

Osalmid Tablets

Approval Number: 国药准字H41020747
Registration: Mar 24, 2025

Desloratadine Oral Solution

Approval Number: 国药准字H20258038
Registration: Mar 24, 2025

Cefoperazone Sodium and Sulbactam Sodium for Injection

Approval Number: 国药准字H20065013
Registration: Mar 23, 2025

桃花散

Approval Number: 国药准字Z20073012
Registration: Mar 21, 2025

Ambroxol Hydrochloride Oral Solution

Approval Number: 国药准字H20258036
Registration: Mar 21, 2025

肥儿散

Approval Number: 国药准字Z20073013
Registration: Mar 21, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.